Arterial hypertension in elderly people

Arterial hypertension is one of the most common diseases, the frequency of which increases with age. Elderly patients are the most vulnerable part of the population and are at risk of complications and deaths, especially in the presence of geriatric syndromes. Somatic diseases, including arterial hypertension, have their own characteristics, aggravate the course of senile asthenia, increase the risk of dependence on assistance, and worsen the prognosis. The article presents the features of clinical manifestations of arterial hypertension in elderly people with senile asthenia. Features of the choice of therapy and combination of the main antihypertensive drugs, starting blood pressure levels for drug therapy, as well as target blood pressure levels in various age groups.

1. Balanova Yu.A., Drapkina O.M., Kutsenko V.A., Imaeva A.E., Kontsevaya A.V., Maksimov S.A., et al. Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study. Cardiovascular Therapy and Prevention. 2023;22(8S):3785. (In Russ.) DOI: 10.15829/1728-8800-2023-3785

2. Tsygankova O.V., Troshina M.S., Latyntseva L.D. Hypertension treatment in elderly patients in 2019: well-known, hot-topics and surprises. Russian Journal of Geriatric Medicine. 2020;(1):64-73. (In Russ.) DOI: 10.37586/2686-8636-1-2020-64-73

3. Kotovskaya Y.V., Kobalava Z.D. Osobennosti arterial'noy gipertonii v starcheskom vozraste. Consilium Medicum. 2004;6(12):888-892. (In Russ.) eLIBRARY ID: 26592426 EDN: WJXZCD

4. Tkacheva O.N., Runikhina N.K., Kotovskaya Yu.V., Sharashkina N.V., Ostapenko V.S. Arterial hypertension management in patients aged older than 80 years and patients with the senile asthenia. Cardiovascular Therapy and Prevention. 2017;16(1):8-21. (In Russ.) DOI: 10.15829/1728-8800-2017-1-8-21

5. Buranova D., Khazanova Kh., Akbarova G., Mukhammadzhanova M. Arterial hypertension:methods of correction in elderly patients. Profilakticheskaya medicina i zdorov'e. 2022;1(1):14-29. (In Russ.) eLIBRARY ID: 59538498 EDN: YGZKTU

6. Filimonova L.A., Yaskevich R.A., Davydov E.L. The issues of formation of arterial hypertension in elderly and senile age. Sovremennye problemy nauki i obrazovaniya. 2016;(6):14. (In Russ.) eLIBRARY ID: 27694707 EDN: XIBDAJ

7. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19(6 Pt 1):508-519. DOI: 10.1161/01.hyp.19.6.508

8. Ostroumova O.D., Cherniaeva M.S., Morozov A.P. Target blood pressure levels in patients with arterial hypertension and frailty. Systemic Hypertension. 2019;16(4):52-60. (In Russ.) DOI: 10.26442/2075082X.2019.4.190577

9. Diehr P, Williamson J, Burke GL, Psaty BM. The aging and dying processes and the health of older adults. J Clin Epidemiol. 2002;55(3):269-278. DOI: 10.1016/s0895-4356(01)00462-0

10. van Bemmel T, Holman ER, Gussekloo J, Blauw GJ, Bax JJ, Westendorp RG. Low blood pressure in the very old, a consequence of imminent heart failure: the Leiden 85-plus Study. J Hum Hypertens. 2009;23(1):27-32. DOI: 10.1038/jhh.2008.79

11. Preobrazhensky D.V. Arterial hypertension of aged: pathogenesis peculiarities and treatment. Clinical gerontology. 2006;12(10):3-13. (In Russ.) eLIBRARY ID: 11642901 EDN: JUUIGV

12. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277(9):739-745. PMID: 9042847.

13. Nedogoda S.V. Diuretics for hypertension from the perspective of novel clinical guidelines and meta-analyzes. Russian Journal of Cardiology. 2021;26(3):4327. (In Russ.) DOI: 10.15829/1560-4071-2021-4327

14. Grachev V.G., Vedenskaya S.S., Smolenskaya O.G. Treatment of Arterial Hypertension in Elderly Patients: Problems and Opportunities. Ehffektivnaya farmakoterapiya. 2023;19(5):44–49. (In Russ.) DOI 10.33978/2307-3586-2023-19-5-44-49

15. Issledovanie HYVET– vazhnejshee klinicheskoe issledovanie 2008 g v rejtinge Obshchestva Klinicheskih Issledovanij i Amerikanskoj Associacii Serdca. Klinicheskaya farmakologiya i terapiya. 2009;8(3):84-85. (In Russ.) eLIBRARY ID: 23454834 EDN: TTGUZZ

16. Davidov E.L., Yaskevich R.A. Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome. Terapevticheskii arkhiv. 2022;94(12):1381-1386. (In Russ.) DOI: 10.26442/00403660.2022.12.201982

17. Ostroumova O.D., Parfenov V.A., Ostroumova T.M., Yakhno N.N., Chazova I.E., Bogolepova A.N., et al. Expert consensus. Effect of antihypertensive therapy on cognitive functions. Systemic Hypertension. 2021;18(1):5-12. (In Russ.) DOI: 10.26442/2075082X.2021.1.200575

18. Ostroumova O.D., Telkova S.S., Dzamihov K.K., Kochetkov A.I., Baronov S.A. Arterial hypertension and cognitive impairment in elderly and senile patients: basic approaches to patient management. Farmateka. 2024;(1):52-61. DOI: 10.18565/pharmateca.2024.1.52-61

19. Karpov YU.A. Calcium channel blockers for the treatment of arterial hypertension and comorbidities. Atmosfera. Novosti kardiologii. 2020;(1):30-37. eLIBRARY ID: 43796118 EDN: PTUQED

20. Borghi C. Lercanidipine in arterial hypertension. Cardiovascular Therapy and Prevention. 2009;8(7):121-129. (In Russ.) eLIBRARY ID: 12998922 EDN: KYLVTJ

21. Marteil N, Lopez-Eady MD, Castro P, Mortoneda E, Luque M. Modifications of the pulse pressure in elderly hypertensives treated with lercanidipine. J Hypertens. 2004;22:S121.

22. Roma J, Sobrino J, Soler-Amigo J. Treatment with lercanidipine during six months in hypertensive elderly patients (more than sixty years). J Hypertens. 2004;20(Suppl 4):S391.

23. Bubnova M.G. Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics. 2022;13(1):31-42. (In Russ.) DOI: 10.17816/22217185.2022.1.201750

24. Nedogoda S.V. Vozmozhnosti felodipina v lechenii arterial'noj gipertenzii. RMZH. 2008;16(21):1416-1418 (In Russ.) eLIBRARY ID: 22935009 EDN: THXBHH

25. Zakharova A.S. Hypertension in older adults: the role of frailty syndrome. Sovremennye problemy nauki i obrazovaniya. 2020;(5):148. DOI: 10.17513/spno.30202

26. Wilhelm-Leen ER, Hall YN, K Tamura M, Chertow GM. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med. 2009;122(7):664-71.e2. DOI: 10.1016/j.amjmed.2009.01.026

27. Ozturk S, Cetin DG, Cetin M, Yilmaz MD, Ozler TE, Cebeci E, et al. Prevalence and Associates of Frailty Status in Different Stages of Chronic Kidney Disease: A Cross-Sectional Study. J Nutr Health Aging. 2022;26(9):889-895. DOI: 10.1007/s12603-022-1839-z

28. Rudenko T.E., Bobkova I.N., Kamyshova E.S., Stavrovskaya E.V. Frailty and chronic kidney disease – the real problem of modern nephrology: A review. Terapevticheskii arkhiv. 2023;95(6):516-520. (In Russ.) DOI: 10.26442/00403660.2023.06.202270

29. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K., Frolova E.V., Ostapenko V.S., Sharashkina N.V., et al. Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology. Rational Pharmacotherapy in Cardiology. 2021;17(4):642-661. (In Russ.) DOI: 10.20996/1819- 6446-2021-07-01.

30. Rivasi G, Tortù V, D'Andria MF, Turrin G, Ceolin L, Rafanelli M, et al. Hypertension management in frail older adults: a gap in evidence. J Hypertens. 2021;39(3):400-407. DOI: 10.1097/HJH.0000000000002685

31. Yamamoto K. Current issues in frailty and hypertension management. Hypertens Res. 2023;46(8):1917-1922. DOI: 10.1038/s41440-023-01310-1

32. Kotovskaya YU.V. Elderly patient with arterial hypertension: focus at therapy individualization. Therapy. 2022;8(9):145-151. DOI: 10.18565/therapy.2022.9.145-151

33. Streit S, Poortvliet RKE, Gussekloo J. Lower blood pressure during antihypertensive treatment is associated with higher all-cause mortality and accelerated cognitive decline in the oldest-old. Data from the Leiden 85-plus Study. Age Ageing. 2018;47(4):545-550. DOI: 10.1093/ageing/afy072

34. Sabayan B, Oleksik AM, Maier AB, van Buchem MA, Poortvliet RK, de Ruijter W, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012;60(11):2014-2019. DOI: 10.1111/j.1532-5415.2012.04203.x

35. Tkacheva O.N., Runikhina N.K., Kotovskaya Yu.V., Sharashkina N.V., Ostapenko V.S. Arterial hypertension management in patients aged older than 80 years and patients with the senile asthenia. Cardiovascular Therapy and Prevention. 2017;16(1):8-21. (In Russ.) DOI: 10.15829/1728-8800-2017-1-8-21